Search Results
Search for other papers by Krzysztof Fujarewicz in
Google Scholar
PubMed
Search for other papers by Michał Jarząb in
Google Scholar
PubMed
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Knut Krohn in
Google Scholar
PubMed
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Search for other papers by Małgorzata Oczko-Wojciechowska in
Google Scholar
PubMed
Search for other papers by Małgorzata Wiench in
Google Scholar
PubMed
Search for other papers by Aleksandra Kukulska in
Google Scholar
PubMed
Search for other papers by Barbara Jarząb in
Google Scholar
PubMed
Search for other papers by Andrzej Swierniak in
Google Scholar
PubMed
). Bootstrap-based multi-gene classification of PTC microarray data Selection of genes is an important goal of microarray studies contributing to broader understanding of the cancer transcriptome as well as yielding novel molecular cancer markers
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Pathology, Department of Pathology, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, Box 802, Boston, Massachusetts 02111, USA
Search for other papers by Ronald R deKrijger in
Google Scholar
PubMed
& Wimalawansa 2015 ). It is now recognized that metastatic potential and patient outcomes vary with genotype of hereditary pheochromocytoma/paraganglioma, and pathologists have begun to search for both morphological and immunohistochemical markers that would
Search for other papers by Ta-Chun Yuan in
Google Scholar
PubMed
Search for other papers by Suresh Veeramani in
Google Scholar
PubMed
Search for other papers by Ming-Fong Lin in
Google Scholar
PubMed
specimens are positively stained with antibodies (Abs) against luminal secretory cell-associated cytokeratins; while they are negative for staining with Abs against basal cell markers, including high molecular weight cytokeratin and p63 ( Wojno & Epstein
Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
Search for other papers by Annunziata Di Domenico in
Google Scholar
PubMed
Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland
Search for other papers by Tabea Wiedmer in
Google Scholar
PubMed
Search for other papers by Ilaria Marinoni in
Google Scholar
PubMed
Search for other papers by Aurel Perren in
Google Scholar
PubMed
markers, such as chromogranin A and synaptophysin, which are used in the histopathological diagnosis. NET are classified as functional or non-functional, depending on syndromes due to inadequate hormone secretion. While functional NET can induce dramatic
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Bruno Ragazzon in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Guillaume Assié in
Google Scholar
PubMed
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Institut Cochin, Inserm, Department of Endocrinology, Université Paris Descartes, CNRS (UMR 8104), 75014 Paris, France
Search for other papers by Jérôme Bertherat in
Google Scholar
PubMed
et al . 1993 , Rainier et al . 1993 , Gicquel et al . 1997 ). Interestingly, it has been previously demonstrated that IGF2 expression could be used as a molecular marker for the diagnosis of ACC ( Gicquel et al . 2001 ). The IGF signaling pathway
Search for other papers by Tanner Freeman in
Google Scholar
PubMed
Search for other papers by Charit Taneja in
Google Scholar
PubMed
Search for other papers by N Paul Ohori in
Google Scholar
PubMed
Search for other papers by Abigail I Wald in
Google Scholar
PubMed
Search for other papers by John Skaugen in
Google Scholar
PubMed
Search for other papers by Linwah Yip in
Google Scholar
PubMed
Search for other papers by Seungwon Kim in
Google Scholar
PubMed
UPMC Hillman Cancer Center, Department of Oncology, Pittsburgh, Pennsylvania, USA
Search for other papers by Robert L Ferris in
Google Scholar
PubMed
Search for other papers by Marina N Nikiforova in
Google Scholar
PubMed
Search for other papers by Somak Roy in
Google Scholar
PubMed
Search for other papers by Yuri E Nikiforov in
Google Scholar
PubMed
2018 ). This association raises the possibility of utilizing molecular markers to detect RCC metastatic to distant sites. ThyroSeq ® version 3 (v3), a targeted next-generation sequencing (NGS) test used for thyroid nodules with indeterminate cytology
Search for other papers by Thais Biude Mendes in
Google Scholar
PubMed
Search for other papers by Bruno Heidi Nozima in
Google Scholar
PubMed
Search for other papers by Alexandre Budu in
Google Scholar
PubMed
Search for other papers by Rodrigo Barbosa de Souza in
Google Scholar
PubMed
Search for other papers by Marcia Helena Braga Catroxo in
Google Scholar
PubMed
Search for other papers by Rosana Delcelo in
Google Scholar
PubMed
Search for other papers by Marcos Leoni Gazarini in
Google Scholar
PubMed
Search for other papers by Janete Maria Cerutti in
Google Scholar
PubMed
). Indeterminate nodules often undergo surgical excision for a definitive diagnosis. For better classification of a disease state and improved clinical decision-making, preoperative molecular markers have been considered. We have previously identified four
Search for other papers by Esther Korpershoek in
Google Scholar
PubMed
Search for other papers by Claudia K Stobbe in
Google Scholar
PubMed
Search for other papers by Francien H van Nederveen in
Google Scholar
PubMed
Search for other papers by Ronald R de Krijger in
Google Scholar
PubMed
Search for other papers by Winand N M Dinjens in
Google Scholar
PubMed
patient 19 did not show LOH with four and six informative markers respectively. This is probably due to the absence of genomic alterations at these loci, but to confirm this more markers should be tested. Molecular heterogeneity could also be due to
Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Department of Biological Sciences, University of Windsor, Windsor, Ontario, Canada
Search for other papers by Martin K Bakht in
Google Scholar
PubMed
Search for other papers by Iulian Derecichei in
Google Scholar
PubMed
Search for other papers by Yinan Li in
Google Scholar
PubMed
Search for other papers by Rosa-Maria Ferraiuolo in
Google Scholar
PubMed
Search for other papers by Mark Dunning in
Google Scholar
PubMed
Search for other papers by So Won Oh in
Google Scholar
PubMed
Search for other papers by Abdulkadir Hussein in
Google Scholar
PubMed
Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Tumor Microenvironment Global Core Research Center, Seoul National University, Seoul, Korea
Cancer Imaging Center, Seoul National University Hospital, Seoul, Korea
Search for other papers by Hyewon Youn in
Google Scholar
PubMed
Department of Pathology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
Search for other papers by Keith F Stringer in
Google Scholar
PubMed
Search for other papers by Chang Wook Jeong in
Google Scholar
PubMed
Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Gi Jeong Cheon in
Google Scholar
PubMed
Search for other papers by Cheol Kwak in
Google Scholar
PubMed
Laboratory of Molecular Imaging and Therapy, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea
Search for other papers by Keon Wook Kang in
Google Scholar
PubMed
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK
Search for other papers by Alastair D Lamb in
Google Scholar
PubMed
Department of Experimental Therapeutics, BC Cancer Research Centre, Vancouver, British Columbia, Canada
Search for other papers by Yuzhuo Wang in
Google Scholar
PubMed
Search for other papers by Xuesen Dong in
Google Scholar
PubMed
Search for other papers by Lisa A Porter in
Google Scholar
PubMed
transmembrane protein prostate-specific membrane antigen (PSMA) is an appealing target for molecular imaging and therapy of AdPC since it is overexpressed in a majority of AdPC tumors and metastatic lesions ( Rai et al . 2016 ). Targeting PSMA is feasible by a
Search for other papers by Catherine Ory in
Google Scholar
PubMed
Search for other papers by Nicolas Ugolin in
Google Scholar
PubMed
Search for other papers by Céline Levalois in
Google Scholar
PubMed
Search for other papers by Ludovic Lacroix in
Google Scholar
PubMed
Search for other papers by Bernard Caillou in
Google Scholar
PubMed
Search for other papers by Jean-Michel Bidart in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
Search for other papers by Ibrahima Diallo in
Google Scholar
PubMed
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
Search for other papers by Florent de Vathaire in
Google Scholar
PubMed
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
Search for other papers by Paul Hofman in
Google Scholar
PubMed
Search for other papers by José Santini in
Google Scholar
PubMed
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
CEA, Department of Nuclear Medicine and Endocrine Oncology, Inserm, Institut Gustave Roussy, Université Paris XI, INSERM ERI-21, University of Nice-Sophia Antipolis, Laboratory of Clinical and Experimental Pathology and CHU-CRLCC-UNSA Tumour/Tissue Bank of Nice Area, Department of Otorhinolaryngology, Institut Curie, CNRS, Université Paris VI, DSV, IRCM, LCE, BP6, Fontenay-aux-Roses F-92265, France
Search for other papers by Bernard Malfoy in
Google Scholar
PubMed
Search for other papers by Sylvie Chevillard in
Google Scholar
PubMed
tumor. Molecular differences between sporadic and radiation-induced thyroid tumors were sought using microarray transcriptome analysis. The first study, including sporadic and post-Chernobyl PTC, did not show any specific radiation-induced gene